Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pharmacological activation of estrogen receptors-α and -β differentially modulates keratinocyte differentiation with functional impact on wound healing

V. Peržeľová, F. Sabol, T. Vasilenko, M. Novotný, I. Kováč, M. Slezák, J. Ďurkáč, M. Hollý, M. Pilátová, P. Szabo, L. Varinská, Z. Čriepoková, T. Kučera, H. Kaltner, S. André, HJ. Gabius, P. Mučaji, K. Smetana, P. Gál,

. 2016 ; 37 (1) : 21-8. [pub] 20150921

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17001001

Estrogen deprivation is considered responsible for many age-related processes, including poor wound healing. Guided by previous observations that estradiol accelerates re‑epithelialization through estrogen receptor (ER)‑β, in the present study, we examined whether selective ER agonists [4,4',4''-(4-propyl [1H] pyrazole-1,3,5-triyl)‑trisphenol (PPT), ER‑α agonist; 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN), ER‑β agonist] affect the expression of basic proliferation and differentiation markers (Ki‑67, keratin‑10, ‑14 and ‑19, galectin‑1 and Sox‑2) of keratinocytes using HaCaT cells. In parallel, ovariectomized rats were treated daily with an ER modulator, and wound tissue was removed 21 days after wounding and routinely processed for basic histological analysis. Our results revealed that the HaCaT keratinocytes expressed both ER‑α and ‑β, and thus are well-suited for studying the effects of ER agonists on epidermal regeneration. The activation of ER‑α produced a protein expression pattern similar to that observed in the control culture, with a moderate expression of Ki‑67 being observed. However, the activation of ER‑β led to an increase in cell proliferation and keratin‑19 expression, as well as a decrease in galectin‑1 expression. Fittingly, in rat wounds treated with the ER‑β agonist (DPN), epidermal regeneration was accelerated. In the present study, we provide information on the mechanisms through which estrogens affect the expression patterns of selected markers, thus modulating keratinocyte proliferation and differentiation; in addition, we demonstrate that the pharmacological activation of ER-α and -β has a direct impact on wound healing.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17001001
003      
CZ-PrNML
005      
20170118113106.0
007      
ta
008      
170103s2016 gr f 000 0|eng||
009      
AR
024    7_
$a 10.3892/ijmm.2015.2351 $2 doi
024    7_
$a 10.3892/ijmm.2015.2351 $2 doi
035    __
$a (PubMed)26397183
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Peržeľová, Vlasta $u Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovak Republic.
245    10
$a Pharmacological activation of estrogen receptors-α and -β differentially modulates keratinocyte differentiation with functional impact on wound healing / $c V. Peržeľová, F. Sabol, T. Vasilenko, M. Novotný, I. Kováč, M. Slezák, J. Ďurkáč, M. Hollý, M. Pilátová, P. Szabo, L. Varinská, Z. Čriepoková, T. Kučera, H. Kaltner, S. André, HJ. Gabius, P. Mučaji, K. Smetana, P. Gál,
520    9_
$a Estrogen deprivation is considered responsible for many age-related processes, including poor wound healing. Guided by previous observations that estradiol accelerates re‑epithelialization through estrogen receptor (ER)‑β, in the present study, we examined whether selective ER agonists [4,4',4''-(4-propyl [1H] pyrazole-1,3,5-triyl)‑trisphenol (PPT), ER‑α agonist; 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN), ER‑β agonist] affect the expression of basic proliferation and differentiation markers (Ki‑67, keratin‑10, ‑14 and ‑19, galectin‑1 and Sox‑2) of keratinocytes using HaCaT cells. In parallel, ovariectomized rats were treated daily with an ER modulator, and wound tissue was removed 21 days after wounding and routinely processed for basic histological analysis. Our results revealed that the HaCaT keratinocytes expressed both ER‑α and ‑β, and thus are well-suited for studying the effects of ER agonists on epidermal regeneration. The activation of ER‑α produced a protein expression pattern similar to that observed in the control culture, with a moderate expression of Ki‑67 being observed. However, the activation of ER‑β led to an increase in cell proliferation and keratin‑19 expression, as well as a decrease in galectin‑1 expression. Fittingly, in rat wounds treated with the ER‑β agonist (DPN), epidermal regeneration was accelerated. In the present study, we provide information on the mechanisms through which estrogens affect the expression patterns of selected markers, thus modulating keratinocyte proliferation and differentiation; in addition, we demonstrate that the pharmacological activation of ER-α and -β has a direct impact on wound healing.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčná diferenciace $x účinky léků $7 D002454
650    _2
$a buněčné linie $7 D002460
650    _2
$a alfa receptor estrogenů $x agonisté $x metabolismus $7 D047628
650    _2
$a beta receptor estrogenů $x agonisté $x metabolismus $7 D047629
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a keratinocyty $x cytologie $x účinky léků $x metabolismus $x patologie $7 D015603
650    _2
$a nitrily $x farmakologie $7 D009570
650    _2
$a fenoly $x farmakologie $7 D010636
650    _2
$a pyrazoly $x farmakologie $7 D011720
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a kůže $x účinky léků $x metabolismus $x patologie $7 D012867
650    _2
$a hojení ran $x účinky léků $7 D014945
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sabol, František $u Department of Heart Surgery, East‑Slovak Institute of Cardiovascular Diseases and Pavol Jozef Šafárik University, Košice, Slovak Republic.
700    1_
$a Vasilenko, Tomáš $u Department of Surgery, Košice‑Šaca Hospital and Pavol Jozef Šafárik University, Košice, Slovak Republic.
700    1_
$a Novotný, Martin $u Department for Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, Košice, Slovak Republic.
700    1_
$a Kováč, Ivan $u Department for Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, Košice, Slovak Republic.
700    1_
$a Slezák, Martin $u Department for Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, Košice, Slovak Republic.
700    1_
$a Ďurkáč, Ján $u Department for Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, Košice, Slovak Republic.
700    1_
$a Hollý, Martin $u Department for Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, Košice, Slovak Republic.
700    1_
$a Pilátová, Martina $u Department of Pathological Anatomy and Physiology, University of Veterinary Medicine and Pharmacy, Košice, Slovak Republic.
700    1_
$a Szabo, Pavol $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Varinská, Lenka $u Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovak Republic.
700    1_
$a Čriepoková, Zuzana $u Department of Pathological Anatomy and Physiology, University of Veterinary Medicine and Pharmacy, Košice, Slovak Republic.
700    1_
$a Kučera, Tomáš $u Institute of Histology and Embryology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kaltner, Herbert $u Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig‑Maximilians‑University Munich, Munich, Germany.
700    1_
$a André, Sabine $u Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig‑Maximilians‑University Munich, Munich, Germany. $7 gn_A_00006374
700    1_
$a Gabius, Hans-Joachim $u Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig‑Maximilians‑University Munich, Munich, Germany.
700    1_
$a Mučaji, Pavel $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Smetana, Karel $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Gál, Peter $u Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovak Republic.
773    0_
$w MED00173213 $t International journal of molecular medicine $x 1791-244X $g Roč. 37, č. 1 (2016), s. 21-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26397183 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170118113213 $b ABA008
999    __
$a ok $b bmc $g 1180141 $s 961568
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 37 $c 1 $d 21-8 $e 20150921 $i 1791-244X $m International Journal of Molecular Medicine $n Int. J. Mol. Med. $x MED00173213
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace